Privia Health Group, Inc. PRVA
19.71
0.32
1.65%
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 89.6×
Follow PRVA
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
166.00 | 131.72 | 121.00 | 116.95 |
P/S ratio |
1.50 | 1.36 | 1.14 | 1.38 | |
P/FCF ratio |
27.69 | 17.76 | 18.55 | 24.80 | |
P/Operating CF |
58.79 | 22.72 | (51.63) | 2,950.08 | |
P/B ratio |
4.01 | 3.66 | 3.17 | 3.87 | |
Price to Tangible BV |
7.23 | 7.93 | 6.66 | 8.04 | |
EV/Sales |
1.28 | 1.14 | 0.95 | 1.20 | |
EV/EBITDA |
70.30 | 54.89 | 44.84 | 49.86 | |
EV/Operating CF |
23.68 | 14.83 | 15.51 | 21.65 | |
EV/FCF |
23.74 | 14.85 | 15.54 | 21.70 | |
Quick Ratio |
1.61 | 1.55 | 1.55 | 1.55 | |
Current Ratio |
1.67 | 1.60 | 1.61 | 1.62 | |
Net Debt/EBITDA |
(25.71) | (34.42) | (39.20) | (27.25) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.64 | 1.69 | 1.73 | 1.71 | |
Operating CF/Net income |
7.58 | 13.93 | (16.14) | 0.12 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.03% | 6.60% | 8.22% | 7.53% | |
Intangible Assets out of Total Assets |
0.25 | 0.31 | 0.30 | 0.29 | |
Share Based Compensation of Revenue |
3.27% | 2.86% | 3.63% | 3.07% | |
Graham Net Nets |
0.13 | 0.11 | 0.14 | 0.12 | |
Graham Number |
4.58 | 5.12 | 4.98 | 5.74 | |
Earnings Yield |
0.60% | 0.76% | 0.83% | 0.86% | |
Free Cash Flow Yield |
3.61% | 5.63% | 5.39% | 4.03% | |
Revenue per Share |
4.73 | 4.43 | 4.86 | 5.02 | |
Operating CF per Share |
0.42 | 1.04 | (0.40) | 0.01 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.42 | 1.04 | (0.40) | 0.01 | |
Cash per Share |
3.60 | 3.93 | 3.38 | 3.27 | |
Shareholders Equity per Share |
6.21 | 6.47 | 6.49 | 6.65 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.21 | 6.47 | 6.49 | 6.65 | |
Free Cash Flow |
51.99 | 127.50 | (49.46) | 1.10 | |
Working Capital |
388.01 | 342.48 | 364.72 | 390.82 | |
Net Current Asset Value |
382.70 | 332.57 | 354.03 | 374.76 | |
EV/EBIT |
92.94 | 70.77 | 58.73 | 63.26 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
1.18% | 1.69% | 0.51% | 1.43% | |
Price to Operating Income |
108.38 | 84.62 | 70.09 | 72.31 | |
| Other line items | |||||
Average Receivables |
454.00 | 358.54 | 451.20 | 509.08 | |
Average Payables |
75.15 | 89.40 | 74.35 | 82.65 | |
Average Assets |
1,248.28 | 1,252.58 | 1,300.72 | 1,380.56 | |
Average Common Equity |
712.47 | 737.20 | 757.72 | 785.81 |
Columns are period end dates